ARMLUPEG
Live / Applied — Statement of use — registration review complete (as of 18 Aug 2026)
What this means for you
Not registered yet, but its 22 Feb 2024 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 98417468
- Mark type
- Stylized text
- Filed
- 22 Feb 2024
- Published for opposition
- 07 May 2024
- Attorney of record
- Robert L Powley
Goods and services
- Class 005 — Pharmaceuticals: biological preparations and medications for the treatment of cancer; biological preparations for use in chemotherapy; pharmaceutical preparations and medications for the treatment of cancer; pharmaceutical preparations for use in chemotherapy; anti-cancer preparations; pharmaceutical preparations for use in stimulating white blood cell production
Owner
- Lupin Inc., Naples, FL, US
- Lupin Inc., Naples, FL, US
Prosecution history
- 08 Sept 2026 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 08 Sept 2026 — REGISTERED-PRINCIPAL REGISTER
- 18 Aug 2026 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 18 Aug 2026 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 18 Aug 2026 — STATEMENT OF USE PROCESSING COMPLETE
- 30 Jun 2026 — USE AMENDMENT FILED
- 30 Jun 2026 — TEAS STATEMENT OF USE RECEIVED
- 05 Dec 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 04 Dec 2025 — SOU EXTENSION 3 GRANTED
- 04 Dec 2025 — SOU EXTENSION 3 FILED
- 04 Dec 2025 — SOU TEAS EXTENSION RECEIVED
- 07 May 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 06 May 2025 — SOU EXTENSION 2 GRANTED
- 06 May 2025 — SOU EXTENSION 2 FILED
- 06 May 2025 — SOU TEAS EXTENSION RECEIVED